Will the mRNA flu vaccine come into being?
At the end of November 2025, the New England Journal of Medicine published an article on a clinical trial of a messenger RNA vaccine against seasonal influenza. The article was written by researchers working for Pfizer, the company that developed the vaccine. Pfizer is keen to show that its vaccine is more effective than conventional vaccines. However, independent experts have pointed out major omissions and inconsistencies in the publication, which minimise or even call into question the trial’s conclusions.
GMO viruses as laboratory tools to be spread in the environment ?
In a recent article, researchers detail several ongoing projects for the genetic modification of viruses. Some of these could be deliberately released into the environment. On February 7, 2024, the European Parliament asked the European Commission to study the potential deregulation of these GMO viruses. A general overview of those projects seems therefore necessary.
“Gain of function” in viruses: research in question
GMOs: sweetened transparency
GMO mosquitoes: Oxitec comes back to Panama
GMO mosquitoes: malaria spurs research
Canada – New GMOs: Missed opportunity for transparency
Brazil: GMO insects to the rescue of Bt corn
Brazil: Endgame for Bayer’s GMO soybean patent?
GM soybeans: unforeseen effects
